Avanos Medical   Report issue

For profit Phase 4
Founded: Alpharetta GA United States (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2014
NCT02475031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Avanos Medical | Halyard Health

Active Ingredients

Drugs in Phase 4 Trials (2)

ketorolac (acuvail) (1 trial)

ropivacaine (naropin) (4 trials)

Drugs in Other Trials (1)

hyaluronic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 3